Financial Data and Key Metrics Changes - Revenue for Q4 2025 was $35 million, down 5% year-over-year but up 2% sequentially from Q3 2025 [16] - Adjusted EBITDA for Q4 was $8.7 million, with an adjusted net income of $3.4 million and adjusted EPS of 16 cents per share [17] - Full year 2025 revenue was $137.4 million, down 4% from 2024, but TRCV grew by 8% in 2025, indicating potential revenue growth in 2026 [18] Business Line Data and Key Metrics Changes - Total Recurring Contract Value (TRCV) reached $144 million, marking an 8% year-over-year increase and the fifth consecutive quarter of sequential growth [4][16] - New sales increased by 86% year-over-year, reflecting effective sales strategies and customer engagement [5] Market Data and Key Metrics Changes - NRC Health serves 74% of the top 100 health systems in the U.S., indicating strong market presence and trust [9] - The company reported a Net Promoter Score of 68, showcasing high customer satisfaction [9] Company Strategy and Development Direction - The company is focused on enhancing its product portfolio and customer engagement strategies to drive growth [5][12] - Investment in AI and product innovation is a strategic priority to deepen differentiation and expand the addressable market [13] - The leadership team has been strengthened to support growth, with new hires bringing extensive healthcare experience [6][8] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to create lasting value amidst the complexities of the healthcare landscape [22] - The company anticipates that the restructuring of its go-to-market strategy will provide a meaningful tailwind for growth in 2026 [12] Other Important Information - The company maintained a disciplined approach to expense management while investing in growth initiatives, achieving a 29% adjusted EBITDA margin [18][19] - A quarterly dividend of 12 cents per share was paid, reflecting confidence in the financial profile [17] Q&A Session Summary - No specific questions or answers were provided in the content regarding the Q&A session.

Core Viewpoint - NRC Health held its Earnings Conference Call for the third quarter ended September 30, 2025, indicating a focus on financial performance and future expectations [2][4]. Group 1: Financial Performance - The earnings press release was made available on the Investor Relations section of NRC Health's website, highlighting the company's commitment to transparency [2]. - The call featured NRC Health's CEO, Trent Green, and the new CFO, Shane Harrison, indicating a leadership focus on financial results [2]. Group 2: Forward-Looking Statements - The call included forward-looking statements regarding expected future results, with a caution that actual results may differ due to various risks and uncertainties [3]. - The company emphasized the importance of understanding these forward-looking statements in the context of their earnings release and SEC filings [3]. Group 3: Non-GAAP Financial Measures - References to non-GAAP financial measures were made during the call, with additional information provided in the earnings press release [4]. - The company provided definitions and reconciliations between non-GAAP and GAAP financial information, ensuring clarity for investors [4].

Core Insights - NRC Health has announced the recipients of its 2025 healthcare experience awards program, highlighting excellence in the healthcare sector [1] Group 1 - The awards program recognizes organizations that have demonstrated outstanding performance in healthcare experience [1] - NRC Health aims to promote best practices and innovations in the healthcare industry through these awards [1]